Regenity

Regenity NEUROCAPSynthetic Capping Device

SHARE

Is a synthetic capping device that is intended for the surgical management of symptomatic end-neuromas.

Most popular related searches

NEUROCAP is a bioresorbable device to protect a peripheral nerve end and separate the nerve from surrounding environment to reduce the development of a symptomatic neuroma (growth of nerve tissue) in patients where nerve tissue has been damaged

NEUROCAP is composed of the bioresorbable copolyester poly. NEUROCAP separates the nerve from the surrounding environment and protects the nerve end. NEUROCAP elicits a minimal acute inflammatory reaction of the surrounding tissue, which is followed by gradual encapsulation of the cap by fibrous tissue. Degradation of NEUROCAP occurs through hydrolysis leading to gradual reduction of molecular weight. NEUROCAP retains sufficient mechanical properties to act as a barrier up to at least 10 weeks, whereafter rapid loss of mechanical strength and gradual mass loss occur. NEUROCAP is resorbed in approximately 16 months. NEUROCAP is a tubular device with one open end and one end sealed, the tip, as indicated in figure 1. An additional hole is included in the tip for easy tissue fixation with a suture. The size of the products is 3cm in length, and NEUROCAP is available in different diameters for different nerves, see table 1. Expected device lifetime is 24 months if stored between -18°C and 8°C.